KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 149 filers reported holding KURA ONCOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $34,942 | -6.9% | 1,697 | -3.5% | 0.00% | 0.0% |
Q1 2024 | $37,520 | +54.4% | 1,759 | +4.1% | 0.00% | +50.0% |
Q4 2023 | $24,303 | +5448.6% | 1,690 | +3420.8% | 0.00% | – |
Q3 2023 | $438 | +129.3% | 48 | +166.7% | 0.00% | – |
Q2 2023 | $191 | -98.9% | 18 | -98.7% | 0.00% | -100.0% |
Q1 2023 | $16,964 | +1596.4% | 1,387 | +2567.3% | 0.00% | – |
Q2 2022 | $1,000 | 0.0% | 52 | -14.8% | 0.00% | – |
Q1 2022 | $1,000 | – | 61 | +281.2% | 0.00% | – |
Q1 2020 | $0 | – | 16 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARCH Venture Management, LLC | 206,307 | $3,363,000 | 11.31% |
Foresite Capital Management IV, LLC | 1,307,982 | $21,320,000 | 10.39% |
EcoR1 Capital, LLC | 4,608,529 | $75,119,000 | 5.55% |
Prosight Management, LP | 685,000 | $11,166,000 | 4.79% |
ACUTA CAPITAL PARTNERS, LLC | 872,500 | $14,222,000 | 4.11% |
BVF INC/IL | 2,775,882 | $45,247,000 | 2.79% |
VR Adviser, LLC | 575,000 | $9,373,000 | 2.24% |
ALETHEA CAPITAL MANAGEMENT, LLC | 216,171 | $3,524,000 | 2.06% |
DAFNA Capital Management LLC | 294,260 | $4,796,000 | 1.38% |
Vivo Capital, LLC | 1,050,000 | $17,115,000 | 1.23% |